Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03964727
Recruitment Status : Suspended (The study has been halted temporarily to mitigate the impact of the COVID-19 pandemic)
First Posted : May 28, 2019
Last Update Posted : March 25, 2020
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : August 2022
Publications: